129 related articles for article (PubMed ID: 37479145)
1. Prostate Cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
Lubarsky R; Ambinder D; Barnett J; Choudhury M; Saji A; Fishman AI; Fullerton S; Phillips JL
Urology; 2023 Oct; 180():28-34. PubMed ID: 37479145
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
3. Disparities in hospitalization outcomes among African-American and White prostate cancer patients.
Naik G; Akinyemiju T
Cancer Epidemiol; 2017 Feb; 46():73-79. PubMed ID: 28056390
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
5. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
6. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
7. Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines.
Abraham N; Wan F; Montagnet C; Wong YN; Armstrong K
J Urol; 2007 Jul; 178(1):82-7; discussion 87. PubMed ID: 17499294
[TBL] [Abstract][Full Text] [Related]
8. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
9. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
10. Racial Discrepancies in Overall Survival among Men Treated with
Zhao H; Howard LE; De Hoedt A; Terris MK; Amling CL; Kane CJ; Cooperberg MR; Aronson WJ; Klaassen Z; Polascik TJ; Vidal AC; Freedland SJ
J Urol; 2020 Feb; 203(2):331-337. PubMed ID: 31479407
[TBL] [Abstract][Full Text] [Related]
11. Differences in Toxicity and Outcomes in Clinical Trial Participants From Minority Populations.
Labriola M; George DJ
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-5. PubMed ID: 33929878
[TBL] [Abstract][Full Text] [Related]
12. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
[TBL] [Abstract][Full Text] [Related]
13. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Barrington WE; Schenk JM; Etzioni R; Arnold KB; Neuhouser ML; Thompson IM; Lucia MS; Kristal AR
JAMA Oncol; 2015 Jun; 1(3):342-9. PubMed ID: 26181184
[TBL] [Abstract][Full Text] [Related]
14. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
Swords K; Wallen EM; Pruthi RS
Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial.
Loeb S; Ravenell JE; Gomez SL; Borno HT; Siu K; Sanchez Nolasco T; Byrne N; Wilson G; Griffith DM; Crocker R; Sherman R; Washington SL; Langford AT
JAMA Netw Open; 2023 Jul; 6(7):e2324395. PubMed ID: 37466938
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
[TBL] [Abstract][Full Text] [Related]
17. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
Hwang C; Henderson NC; Chu SC; Holland B; Cackowski FC; Pilling A; Jang A; Rothstein S; Labriola M; Park JJ; Ghose A; Bilen MA; Mustafa S; Kilari D; Pierro MJ; Thapa B; Tripathi A; Garje R; Ravindra A; Koshkin VS; Hernandez E; Schweizer MT; Armstrong AJ; McKay RR; Dorff TB; Alva AS; Barata PC
JAMA Netw Open; 2023 Sep; 6(9):e2334208. PubMed ID: 37721753
[TBL] [Abstract][Full Text] [Related]
19. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
20. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
Eastham JA; Kattan MW
J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
